BIOCON.NSBIOCON.NSNSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
-3.9%/yr
vs -1.5%/yr prior
5Y CAGR
-1.8%/yr
Consistent
Acceleration
-2.5pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 21.08% | +3.0% |
| 2025 | 20.47% | -7.7% |
| 2024 | 22.17% | -6.8% |
| 2023 | 23.78% | -0.5% |
| 2022 | 23.91% | +3.4% |
| 2021 | 23.13% | -8.6% |
| 2020 | 25.31% | +0.3% |
| 2019 | 25.24% | +25.8% |
| 2018 | 20.06% | -20.5% |
| 2017 | 25.23% | - |